22 Jul ARMI | BioFabUSA
Jennifer MacDonald, M.D., Chief Operating Officer
Oct. 6 | 11:15am | FLW Ballroom G
Manchester, NH
(Private)
The Advanced Regenerative Manufacturing Institute (ARMI), through its BioFabUSA program, is accelerating the commercial readiness of regenerative medicine by bridging the gap between early innovation and large-scale manufacturing. ARMI supports more than 175 member organizations—from startups to global biotech leaders—by providing access to enabling technologies, bioprocessing expertise, and regulatory and commercialization support. Through its BioFab Startup Lab, ARMI helps early-stage companies de-risk manufacturing and prepare for clinical and market milestones. By addressing core challenges such as automation, standardization, and talent development, ARMI is building the advanced manufacturing capacity needed to bring cell-based therapies, engineered tissues, and regenerative technologies to patients. With strong national partnerships and infrastructure in place, ARMI plays a critical role in strengthening domestic biomanufacturing capabilities and reducing time to market for advanced therapies.
